From Evidence to Practice: Advances in Malignant Pleural Effusion Management
Nicholas Pastis, MD
Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Brian P. McDonough, MD, FAAFP
David A. Johnson, MD, FACG, FACP
Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
John Cho, MD, PhD, FRCPC
From Durability to Discovery: Advances in ALK+ mNSCLC Treatment
Angel Qin, MD
How Novel Strategies Could Push ALK+ mNSCLC Care Forward
How ALK Vaccines Could Prolong TKI Response in mNSCLC
Investigating Unanswered Questions in ALK+ mNSCLC Care
Alice T. Shaw, MD, PhD
CAR T-Cell vs Bispecific Therapies for R/R Multiple Myeloma: How They Compare
Charles Turck, PharmD, BCPS, BCCCP
Krina Patel, MD, MSc
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Alexandria May, PharmD, BCPS
Shannon Raber, MS, CPNP, RN
Bridget Archambault, MSN, CPNP
Antibody-Drug Conjugates for NSCLC: How They Work and Who’s a Candidate
Laura Alder, MD
Emerging Biomarker Research for NSCLC Antibody-Drug Conjugates
Christine Bestvina, MD
A Patient-First Approach to Smoking Cessation and Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
Managing Antibody-Drug Conjugate Toxicities in NSCLC Care
Innovations Shaping the Future of Antibody-Drug Conjugates in NSCLC
The Importance of Multidisciplinary Coordination in NSCLC Care
Smarter Screening for Non-Small Cell Lung Cancer
Jobelle Baldonado, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.